Femasys Announces Financial Results for Quarter Ended September 30, 2026 and Provides Corporate Update

$30 million private placement supports commercial team build-out to drive U.S. sales growth; Q3 U.S. sales increased slightly despite significant funding constraints prior to mid-August financingATLANTA, Nov. 13, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. NASDAQ:FEMY, a leading biomedical innovator deve…